Background The objective of the current study was to investigate both short-and long-term outcomes of patients undergoing curative-intent resection for intrahepatic cholangiocarcinoma (ICC) stratified by extent of hepatic resection relative to overall final pathological margin status. Methods One thousand twenty-three patients with ICC who underwent curative-intent resection were identified from a multiinstitutional database. Demographic, clinicopathological, and operative data, as well as overall (OS) and recurrence-free survival (RFS) were compared among patients undergoing major and minor resection before and after propensity score matching. Results Overall, 608 (59.4%) patients underwent major hepatectomy, while 415 (40.6%) had a minor resection. Major hepatectomy was more frequently performed among patients who had large, multiple, and bilobar tumors. Roughly half of patients (n = 294, 48.4%) developed a postoperative complication following major hepatectomy versus only one fourth of patients (n = 113, 27.2%) after minor resection (p < 0.001). In the propensity model, patients who underwent major hepatectomy had an equivalent OS and RFS versus patients who had a minor hepatectomy (median OS, 38 vs. 37 months, p = 0.556; and median RFS, 20 vs. 18 months, p = 0.635). Patients undergoing major resection had comparable OS and RFS with wide surgical margin (≥10 and 5-9 mm), but improved RFS when surgical margin was narrow (1-4 mm) versus minor resection in the propensity model. In the Cox regression model, tumor characteristics and surgical margin were independently associated with long-term outcome. Conclusions Major hepatectomy for ICC was not associated with an overall survival benefit, yet was associated with increased perioperative morbidity. Margin width, rather than the extent of resection, affected long-term outcomes. Radical parenchymalsparing resection should be advocated if a margin clearance of ≥5 mm can be achieved.
Introduction
Intrahepatic cholangiocarcinoma (ICC) is the second most common type of primary liver cancer after hepatocellular carcinoma (HCC), accounting for 5-30% of all primary hepatic malignancies. [1] [2] [3] ICC originates from malignant transformation of intrahepatic biliary epithelial cells. While rare, the incidence of ICC has increased from 0.44 to 1.18 cases per 100,000 between 1973 and 2012 in the USA with the incidence continuing to increase worldwide. 4 The rise in the reported number of ICC cases is undoubtedly multifactorial and may be due to better imaging, more disease-specific histopathologic techniques, as well as an increase in the prevalence of certain risk factors. 4, 5 While rare, ICC is an aggressive disease with outcomes that are typically worse than HCC. 5, 6 For patients with ICC, hepatic resection remains the best therapeutic approach; however, less than 40% of ICC patients are potential candidates for resection due to advanced disease at presentation. 5, 7 Among patients who are candidates for surgery, 5-year survival following curative-intent resection ranges from only 30 to 50%. 2 Both biological and technical factors are associated with survival after resection of ICC. In particular, lymph node metastasis, tumor size, number, and grade are all associated with long-term outcomes. [8] [9] [10] [11] In addition, our group had previously reported that R1 margin status was associated with inferior long-term outcomes. 8 In fact, we reported that there was an incremental worsening of recurrence-free and overall survival as margin width decreased. Obtaining a wider surgical margin often necessitates, however, a more extensive hepatic resection. While major hepatectomy, defined as resection of three or more liver segments, 12 may facilitate a wider surgical margin and potential removal of tumor-bearing portal tributaries, perioperative morbidity and mortality may be higher compared with minor resection. [13] [14] [15] While previous studies have advocated for parenchymal sparing, minor resections for diseases such as colorectal liver metastasis, other reports have noted an improvement in outcomes following large, anatomic resections of other diseases such as HCC. 13, [16] [17] [18] The impact of resection extent, specifically the type of liver resection (i.e., minor vs. major), on outcomes following resection of ICC has not been examined. Given the lack of data on long-term outcomes following minor versus major hepatectomy for ICC, the objective of the current study was to investigate both short-and long-term outcomes stratified by extent of hepatic resection relative to overall final pathological margin status. In addition, we sought to define the relative survival benefit of achieving additional margin width compared with any potential detrimental complication-related effects on long-term prognosis.
hepatectomy, type and extent of vascular resection, receipt of lymphadenectomy, margin status, operative time, estimated blood loss, and intraoperative blood transfusion. Tumor size, number, morphology, vascular/perineural/biliary/adjacent organ invasion, lymph node metastasis, histological grade, and resection margin were ascertained based on the final pathology report. Types of hepatic resection were defined according to the consensus classification. 12 Major hepatectomy was defined as the resection of three or more segments (right hepatectomy, left hepatectomy, extended right hepatectomy, extended left hepatectomy, and any trisegmentectomy), whereas minor resection included resection of two or fewer segments and non-anatomic wedge resection according to the classification of Couinaud. 19 Data on tumor stage were collected according to the American Joint Committee on Cancer (AJCC) 7th edition staging system. 20 Primary outcomes were overall survival (OS) and recurrence-free survival (RFS), both calculated from the date of surgery. Recurrence was defined as identification of suspicious imaging findings or biopsy-proven tumor. Recurrent sites were divided as intrahepatic and/or extrahepatic. Secondary outcomes were postoperative morbidity and mortality at 30 and 90 days following surgery. Postoperative complications were graded according to the Clavien-Dindo classification (CDC) of surgical complication. 21 
Statistical Analysis
Numerical variables were expressed as medians with interquartile ranges (IQR) and compared with student t test or Mann-Whitney U test between the two groups. Nominal variables were expressed as number and percentages and compared with Chi-squared test or Fisher's exact test. KaplanMeier survival analyses were used to compare survival using the log-rank test between any two groups. Potential risk factors associated with OS and RFS were identified using univariate and multivariable Cox hazard regression models after exclusion of patients who died within 90 days postoperatively (n = 60), and expressed as hazard ratio (HR) and 95% confidence interval (CI). Factors with p value <0.1 by univariate analysis were included in multivariable analysis.
Since patients who underwent major and minor hepatectomy groups were not randomly distributed, propensity score matching (PSM) was used to mitigate selection bias. Specifically, variables potentially affecting long-term outcomes were utilized in the propensity score based on identification in logistic regression analysis. Propensity score analysis with 1:1 matching was performed without replacement using a caliper with a width 0.1 of the standard deviation to generate matched pairs of the patients. In all analyses, two-tailed p value <0.05 was considered statistically significant. Statistical analysis was carried out using SPSS 22.0 (Chicago, IL, USA).
Results

Baseline Demographic and Clinicopathological Characteristics
The median age of the 1023 patients with ICC was 59 years (IQR, 51-68 years); the majority were male (n = 569, 55.6%) and Caucasian (n = 539, 52.7%). Overall, 608 (59.4%) patients underwent major hepatectomy, while 415 (40.6%) had a minor resection. Patients undergoing major hepatectomy were older, more likely to be female, and more often presented with clinical jaundice (Table 1) . Major hepatectomy was more frequently performed among patients who had large, multiple, and bilobar tumors. Patients undergoing major hepatectomy were also more likely to have advanced disease characterized by vascular, biliary, perineural, and adjacent tissue invasion, as well as poor tumor differentiation (Table 1) . Interestingly, patients who underwent a major hepatectomy were more likely to have a microscopically positive (R1) margin than patients who underwent minor resection (p < 0.001, Table 1 ).
Association of Resection Extent with Shortand Long-Term Outcomes
Not surprisingly, major hepatectomy was associated with longer operative times, a larger volume of intraoperative blood loss, and more frequent intra-and postoperative transfusion of packed red blood cells (Table 1) . Consequently, almost one half of patients (n = 294, 48.4%) developed a postoperative complications following major hepatectomy versus only one fourth of patients (n = 113, 27.2%) after minor resection (p < 0.001). Moreover, major complications (CDC III-IV) and postoperative death (CDC V) were more common after a major versus minor hepatic resection (both p < 0.01), while minor complications (CDC I-II) were comparable (p = 0.303, Table 2 ). Major hepatectomy was associated with more frequent surgical technique-related (anastomotic leakage, intra-abdominal abscess, liver failure, cholangitis, and bowel perforation/ileus), medical (respiratory insufficiency, pulmonary embolism, renal failure, and cardiac events), and infectious (systemic, urinary tract, and wound infection) complications (Table 2 ). In turn, readmission and perioperative mortality were higher among patients after major versus minor hepatectomy (all p < 0.01). Among all patients, median, 1-, 3-, and 5-year OS was 37 months, 78%, 51%, and 39%, respectively. During followup, 611 (60%) patients experienced a tumor recurrence; median, 1-, 3-, and 5-year RFS was 17 months, 57%, 36%, and 31%, respectively. The recurrence site was intrahepatic tumor only in most patients (n = 429/611; 70%) ( Table 2) . Interestingly, patients undergoing major liver resection had a worse OS, yet a similar RFS compared with patients who underwent a minor resection (median OS, 34 vs. 49 months, p = 0.004; median RFS, 16 vs. 19 months, p = 0.151; Fig. 1a, b) . A Cox regression model was performed to identify risk factors associated with overall and recurrence-free survival of 963 patients after exclusion of patients who died within 90 days following surgery (n = 60). On multivariable analysis, tumor characteristics, surgical margin width, and intraoperative blood transfusion were associated with OS and RFS, yet not resection extent (major vs. minor) (Tables 3 and 4) .
Given the baseline differences in the minor versus major hepatectomy cohorts, PSM was then utilized to generate 290 pairs of well-matched patients with similar tumor size, number, distribution, vascular invasion, surgical margin width, incidence and severity of postoperative complications, and in hospital mortality (Supplementary Table 1 ). In the propensity model, patients who underwent major hepatectomy had equivalent OS and RFS as patients who had a minor hepatectomy (median OS, 38 vs. 37 months, p = 0.556; and median RFS, 20 vs. 18 months, p = 0.635, Fig. 1c, d) .
Outcomes of Patients with Different Width of Surgical Margin
Given that surgical margin may be associated with the extent of resection, patients who underwent R0 resection were stratified into three groups with different margin width: ≥10, 5-9, and 1-4 mm. The impact of major versus minor resection on OS and RFS using PSM was then assessed (Supplementary Fig. 1 Overall survival (a, c) and recurrence-free survival (b, d) before and after propensity score matching of patients undergoing major and minor hepatectomy for intrahepatic cholangiocarcinoma Table 2 ). Patients with a wide surgical margin (≥10 or 5-9 mm) demonstrated no difference in OS and RFS when stratified by major versus minor resection before and after PSM ( Supplementary Fig. 1A, B, Fig. 2a, b) . Interestingly, patients who underwent a major resection with a narrow surgical margin (1-4 mm) had a worse OS (Supplementary Fig. 1C ). However, after PSM, patients who underwent a major hepatectomy with a narrow surgical margin were noted to have a comparable OS versus patients undergoing a minor hepatectomy with close margins. In contrast, patients who underwent a major hepatectomy with close surgical margins had an improved RFS versus minor resection after matching for tumor characteristics, postoperative complications, and mortality on PSM (Fig. 2c) .
Discussion
Surgical resection is the best curative treatment option for ICC and may provide patients with a chance for long-term survival. 8, 22, 23 At the time of surgery, the extent of liver resection for a liver tumor is typically determined by tumor size, number, and location, as well as underlying quality of the non-tumorous liver. 24, 25 Whether major hepatectomy is necessary and superior to minor resection in improving the long-term survival of patients with HCC and CRLM has been a long-standing topic of interest. [13] [14] [15] [16] 26 Major hepatectomy may be associated with wider surgical margins and theoretical removal of tumor-bearing portal tributaries, yet it sacrifices a large volume of functional liver parenchyma with higher postoperative morbidity and mortality than minor hepatectomy. [13] [14] [15] The extent of hepatic resection and its impact on outcomes among patients with ICC has not been well examined. The current study is important because it specifically investigated the impact of extent of resection on both short-and long-term outcomes, as well as assessed the influence of resection extent relative to margin width using both unadjusted and PSM analyses. Of note, extent of hepatic resection did not impact OS among patients with a wider P values from the multivariable models which are significant are in italics surgical margin (≥5 mm). Therefore, the findings of the present study suggest that a radical resection with parenchymal preservation should be recommended whenever possible, as long as an adequate margin width (≥5 mm) can be achieved. A major hepatectomy has been advocated for HCC tumors >5 cm, as a more extensive resection allows for removal of a wider surgical margin, as well as any microscopic disease along the portal tributaries. 27 Because a large portion of the resected liver is typically occupied by the large tumor mass, loss of functional liver parenchyma is typically minimal compared with major hepatectomy for small HCC. 26 For small HCC (<5 cm), the role of major hepatectomy remains controversial. 26, [28] [29] [30] In fact, several studies have noted that preservation of liver parenchyma should take priority, and minor hepatectomy can provide equal OS and RFS compared with major hepatectomy for small HCC. 16, 31 For patients with CRLM, several studies have noted that the extent of hepatectomy is not associated with outcomes, with most studies favoring parenchymal-sparing operations for CRLM. 13, 18, 32, 33 In the current study specifically investigating ICC patients, major hepatectomy was performed in the majority (59%), including hemihepatectomy (36%) or extended hemihepatectomy (22%). Of note, the utilization of major hepatectomy for ICC was higher than that reported in many studies on HCC (5-39%). 26, 34 The reason for this is likely multifactorial and may be related to the more aggressive nature of ICC and the infrequency of liver cirrhosis (10%), which allowed for more major resections without the fear of liver insufficiency.
Notably, almost one half of the patients (48.4%) undergoing major resection experienced a postoperative complication versus only 27% of patients who underwent a minor resection. Of note, one fourth of patients had a severe complication (CDC ≥III) after a major hepatectomy.
The occurrence of a postoperative complication has previously been reported to be an independent predictor of worse long-term outcomes. 35 In the current study, after exclusion of patients who died within 90 days following P values from the multivariable models which are significant are in italics surgery, postoperative complications were not independently associated with either OS or RFS. Examination of the Kaplan-Meier curves suggested that the impact of major complications on survival was primarily in the immediate post-operative period rather than in the long term. These data suggest that the increased complications associated with major hepatectomy may have an adverse short-term effect on mortality risk. When matched for tumor characteristics, surgical margin width, postoperative complications, and mortality, patients Fig. 2 Overall survival (OS) and recurrence-free survival (RFS) of patients undergoing major and minor hepatectomy with surgical margin ≥10 mm (a), 5-9 mm (b), and 1-4 mm (c) after propensity score matching who underwent major hepatectomy had a comparable OS and RFS compared with patients undergoing minor resection. Our previous work had demonstrated that surgical margin width was associated with long-term outcomes. 8 Interestingly, in the current study, patients undergoing major hepatectomy were more likely to have an R1 margin. This finding might be explained by the fact that patients with larger and more difficult tumors more frequently underwent a major resection. However, among patients who had an R0 resection, surgical margin width was not different for patients undergoing a major versus minor resection. On subgroups analysis stratifying patients according to margin width, patients undergoing major resection had similar outcomes to patients undergoing minor resection, as long as the surgical margin was wider than 5 mm. In contrast, when the surgical margin was narrow (1-4 mm), major resection was associated with a decrease in tumor recurrence compared with minor resection. One possible explanation is that ICC arises from intrahepatic biliary ducts and tends to disseminate into the portal venous system. Major hepatectomy may be more likely to remove the entire unilobar portal venous drainage of the involved lobe of the liver. However, unlike HCC, ICC mostly originates in a noncirrhotic liver and is therefore less likely to be multi-centric. As such, the potential superiority of major hepatectomy in eradicating microscopic metastatic lesions might be less when the surgical margin is adequate (≥5 mm). However, when the closest margin of tumor is narrow (<5 mm), major hepatectomy may have an effect of eradicating microscopic metastatic lesions as evidenced by decreased tumor recurrence.
There were several limitations of the current study. First, as a retrospective study, there was selection bias regarding patients undergoing major or minor resection. To mitigate this bias, we utilized PSM to create groups that were wellmatch on known prognostic risk factors (e.g., tumor size, number, vascular invasion, surgical margin, and postoperative morbidity). We were also unable to discern Btrue^ana-tomic versus non-anatomic resections at the sub-lobar level, as strict anatomic segmentectomy is not commonly performed in most institutions. Therefore, it was not possible to define and compare all Btrue^anatomic and nonanatomic resections.
In conclusion, extent of liver resection was not a driving factor affecting long-term outcome of patients with ICC. However, tumor factors and surgical margin impacted long-term outcomes. Importantly, major hepatectomy was associated with increased perioperative mortality and morbidity. Taken together, the data suggest that major hepatectomy for ICC does not provide a survival benefit, yet is associated with increased perioperative morbidity. Margin width, rather than the extent of resection, did impact longterm outcomes, and radical parenchymal-sparing resection should be advocated if a margin clearance of ≥5 mm can be achieved.
